ICR responds to NICE approval of palbociclib for treating advanced breast cancer after hormone therapy
The Institute of Cancer Research, London, welcomes the approval by NICE of the innovative targeted…
Browsing: palbociclib
ASCO 2019: New blood test predicts breast cancer’s return at start of treatment
A new blood test for women with breast cancer can predict how well patients will…
Breast cancer drug could be used to treat life-threatening leukaemia
A recently-approved breast cancer drug could be used to target and treat a life-threatening leukaemia,…
Blood test could quickly predict if the drug palbociclib will help breast cancer patients
A new study has found a blood test for cancer DNA could predict if a…
Study shows biomarkers can predict which ER-positive breast cancer patients respond best to first-line therapy
Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been an inability to…
Spider web of cancer proteins reveals new drug possibilities
Scientists at Winship Cancer Institute of Emory University have mapped a vast spider web of…
Tucatinib progressing in pivotal trial against HER2 breast cancer
Phase 1 clinical trial data published this week in the journal Clinical Cancer Research show early promise of…
ASCO 2016: New Treatment for Advanced Breast Cancer Doubles Progression Free Survival Rates
New practice changing clinical trial results show that for postmenopausal women with advanced or metastatic…